In a recent trend, the government is increasing investigations and prosecutions of pharmacies alleging health care fraud and False Claims Act (“FCA”) violations based on inventory shortages. Multiple governmental offices, including the... Read More
Blogs & Articles | Community, Retail Pharmacies | Federal and State Fraud and Abuse Counseling | Life Sciences | Pharmacy Law | White Collar Criminal Defense & Government Investigations

In November 2020, the U.S. Department of Health & Human Services, Office of Inspector General (the “OIG”) issued a Special Fraud Alert to highlight the fraud and abuse risks associated with pharmaceutical and medical device company speaker... Read More
Blogs & Articles | Professional Board Actions | Professional Practice Representation | White Collar Defense and Government Investigation

As the opioid crisis continues to result in devastating consequences throughout the country, the U.S. Department of Justice (the “DOJ”) is broadening its opioid enforcement to all stakeholders involved in the opioid supply chain including,... Read More
Blogs & Articles | Community, Retail Pharmacies | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

On September 30, 2020, the Department of Justice (“DOJ”) announced a nationwide healthcare fraud and opioid takedown resulting in charges against more than 100 physicians for over $4.5 billion in losses connected to allegedly fraudulent... Read More
Healthcare | Telehealth and Telemedicine